Search clinical trials for: insulin pump

Total 10287 results

Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Novo Nordisk A/S

Completed

Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

Diabetes Mellitus, Type 1

United States
McGill University

Completed

Safety and Efficacy of Artificial Pancreas With and Without a Meal Detection Module on Glycemic Control in Adolescents With Type 1 Diabetes After a Missed Bolus

Diabetes Mellitus, Type 1

Canada
Groupe Hospitalier Pitie-Salpetriere

Completed

Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients (FREESTYLE)

Diabetes Mellitus, Type 1 | Glucose Metabolism Disorders (Including Diabetes Mellitus)

France
Eli Lilly and Company
Insulet Corporation

Completed

An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus (VIVID)

Type 2 Diabetes Mellitus

United States, Puerto Rico
Eli Lilly and Company

Completed

A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

Diabetes Mellitus, Type 1

Germany
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3)

Type 1 Diabetes Mellitus

United States
University of Virginia
LifeScan

Completed

Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Metabolic Research Institute, Inc.

Unknown

Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance

Type 1 Diabetes Mellitus

United States
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Diabeloop for Kids (DBL4K)

Diabetes Mellitus, Type 1 | Closed Loop | Young Children (6 to 12 Years Old )

Belgium, France
LMC Diabetes & Endocrinology Ltd.
Insulet Corporation

Completed

Canadian Real-World Outcomes of Omnipod Initiation in People With T1D (COPPER)

Diabetes Mellitus, Type 1

Canada
Medtronic Diabetes
Medtronic Poland Spółka z ograniczoną odpowiedzialnością

Completed

Orchestra Pregnancy Observational Study in Poland

Pregnancy | Type 1 Diabetes Mellitus

Poland
Medtronic Diabetes

Completed

Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes (SMILE)

Type 1 Diabetes

Netherlands, France, Italy, United Kingdom
Boston Children's Hospital

Completed

Adjusting Insulin Delivery to Activity (AIDA)

Diabetes | Nocturnal Hypoglycemia

United States
Arizona State University
Mayo Clinic

Withdrawn

Evaluation of iDECIDE: A Smartphone App for Insulin Dosing Accounting for Alcohol and Exercise

Type 1 Diabetes
Rabin Medical Center
GIF

Withdrawn

Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes

Type 1 Diabetes

Germany, Israel
Rabin Medical Center
Juvenile Diabetes Research Foundation; University of Padova; Jaeb Center for... and other collaborators

Completed

Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility Study

Type1diabetes

Israel
Rabin Medical Center
The Leona M. and Harry B. Helmsley Charitable Trust; DreaMed

Completed

Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study (Advice4U)

Type1 Diabetes Mellitus

United States, Germany, Israel, Slovenia
Bruce A. Buckingham

Completed

Medtronic Minimed Overnight Closed-Loop System

Type 1 Diabetes Mellitus | Autoimmune Diabetes | Juvenile-Onset Diabetes | Diabetes, Mellitus, Type 1

United States
Aristotle University Of Thessaloniki

Unknown

Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

Type 1 Diabetes

Greece
Imperial College London

Completed

Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals

Type 1 Diabetes

United Kingdom
University of Edinburgh
NHS Lothian

Terminated

Energy Balance Following Islet Transplantation (EBFIT)

Type 1 Diabetes

United Kingdom
J.H. DeVries
Rijnstate Hospital; Inreda Diabetic B.V.

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, (APPEL5)

Diabetes Mellitus, Type 1

Netherlands
Peking Union Medical College Hospital

Unknown

Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative Period

China
Stanford University
University of Colorado, Denver

Completed

Hyaluronidase Effect on Infusion Set Life

Type 1 Diabetes Mellitus

United States
Medtronic Corporate Technologies and New Ventures

Completed

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (COPE-HCV)

Hepatitis C

United States
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Diabetes Type 1

United States, Spain
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
Sidra Medical and Research Center

Completed

Evaluation of Minimed 670G in T1D Patients on Multiple Daily Injection

Diabetes Mellitus, Type 1

Qatar
Christchurch Clinical Studies Trust Ltd
Medtronic

Unknown

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Type1diabetes

New Zealand
Groupe Hospitalier de la Region de Mulhouse et...

Completed

Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes (IM-CAPT)

Type1diabetes

France
Boston Children's Hospital

Completed

Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)

Type 1 Diabetes | Biomedical Technology

United States
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Type 1 Diabetes
Medtronic Diabetes

Terminated

Qingdao: Insulin Pump Follow-Up Program

Type 1 Diabetes

China
Institut de Recherches Cliniques de Montreal
Réseau de recherche en santé cardiométabolique, diabète et obésité

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy

Type 2 Diabetes

Canada
Medtronic Diabetes

Completed

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Novo Nordisk A/S

Completed

A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

Diabetes Mellitus, Type 1

United States
Samsung Medical Center

Unknown

Structured Education Based on New Glucose Management Devices in Patients With Type 1 Diabetes Mellitus (Education)

Type 1 Diabetes Mellitus

Korea, Republic of
Medtronic Diabetes

Completed

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Diabetes

United States
Medical University of Vienna
Medical University of Graz; Charite University, Berlin, Germany; Hospital del...

Completed

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients (ITP-NODAT)

Hyperglycemia
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Halozyme Therapeutics

Completed

A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20) (HALO-117-406)

Type 1 Diabetes Mellitus

United States
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7) (WP7)

Diabetes Mellitus, Type 1 | Closed Loop

France
Massachusetts General Hospital
Boston University

Completed

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Type 1 Diabetes

United States
University of Texas Southwestern Medical Center

Withdrawn

Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.

Cystic Fibrosis Related Diabetes

United States
Rabin Medical Center
Novo Nordisk A/S; DreaMed

Terminated

Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study

Type 1 Diabetes

Israel
Medtronic Diabetes

Completed

Obtain a Good Blood Glucose Control With the Paradigm Real Time System (RTD)

Type 1 Diabetes

France
Massachusetts General Hospital

Completed

The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance

Type 1 Diabetes | Type 2 Diabetes

United States

3

Subscribe